Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
486 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00479674 | Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer(ABC) | completed | Phase 2 | 41 | Duke UniversityOTHER | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00447330 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma(XAGastric) | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Feb 13, 2015 |
| clinicaltrials |
| NCT01017497 | Optimal Planning Target Volume With Stereotactic Radiosurgery | completed | N/A | 49 | Duke UniversityOTHER | 1 | Feb 13, 2015 | clinicaltrials |
| NCT01990066 | Home Based Exercise Program for Elderly Cancer Patients | terminated | N/A | 8 | Duke UniversityOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01207102 | Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 10 | Duke UniversityOTHER | 2 | Dec 15, 2014 | clinicaltrials |
| NCT00815295 | Study of Sorafenib/Cetuximab in Head and Neck Cancer | completed | Phase 1 / Phase 2 | 31 | Duke UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT00862810 | Alternate Dosing Schedules Study for HPV Vaccine(ADS) | completed | Phase 4 | 72 | Duke UniversityOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT01873482 | Traditional African Healing Ceremony in a U.S. Population | completed | N/A | 17 | Duke UniversityOTHER | 1 | Nov 3, 2014 | clinicaltrials |
| NCT02280642 | Alternate Dosing Schedules Study for HPV Vaccine (ADS)(ADS) | completed | — | 331 | Duke UniversityOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT00918385 | Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer(ARS) | terminated | Phase 2 | 57 | Duke UniversityOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT01473342 | Mila Blooms Intervention Study | completed | N/A | 21 | Duke UniversityOTHER | 1 | Oct 24, 2014 | clinicaltrials |
| NCT01952886 | Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients | withdrawn | Phase 2 | 0 | Duke UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00134680 | Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC | completed | Phase 2 | 33 | Duke UniversityOTHER | 1 | Sep 16, 2014 | clinicaltrials |
| NCT02127372 | Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 | terminated | Phase 1 / Phase 2 | 43 | Duke UniversityOTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT00994578 | Intervention Study of Communication in Oncologist-Patient Encounters(COPE) | completed | N/A | 659 | Duke UniversityOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT00057915 | Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer | completed | Phase 1 | 4 | Duke UniversityOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00509366 | Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer(TOP0602) | terminated | Phase 2 | 101 | Duke UniversityOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00005951 | Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma | completed | Phase 1 | — | Duke UniversityOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00003461 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors | completed | Phase 1 / Phase 2 | — | Duke UniversityOTHER | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00005081 | Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma | completed | Phase 2 | — | Duke UniversityOTHER | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00616005 | Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide | completed | Phase 2 | 41 | Duke UniversityOTHER | 1 | Aug 18, 2014 | clinicaltrials |
| NCT00672594 | Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy | completed | Phase 2 | 30 | Duke UniversityOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00673283 | Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging | completed | Early Phase 1 | 86 | Duke UniversityOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00345891 | Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project) | completed | N/A | 496 | Duke UniversityOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00504725 | Ketamine In Thoracic Surgery (KITS) Trial(KITS) | completed | Phase 2 | 40 | Duke UniversityOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT02159482 | Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines | terminated | Phase 2 | 11 | Duke UniversityOTHER | 0 | Jul 25, 2014 | clinicaltrials |
| NCT00352521 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma | completed | Phase 2 | 20 | Duke UniversityOTHER | 1 | Jul 22, 2014 | clinicaltrials |
| NCT00268359 | Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas | completed | Phase 2 | 68 | Duke UniversityOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00545948 | Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer(TOP0703) | terminated | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00611728 | Ph I SU011248 + Irinotecan in Treatment of Pts w MG | completed | Phase 1 | 25 | Duke UniversityOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00586755 | Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma | completed | Phase 2 | 48 | Duke UniversityOTHER | 0 | Jul 18, 2014 | clinicaltrials |
| NCT00002752 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers | completed | Phase 1 / Phase 2 | — | Duke UniversityOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00314808 | A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas | completed | Phase 1 | 33 | Duke UniversityOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00609999 | Ph I Dasatinib + Erlotinib in Recurrent MG | completed | Phase 1 | 47 | Duke UniversityOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00612989 | Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | completed | Phase 1 | 42 | Duke UniversityOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00932490 | Tailored Intervention Protocol for Oral Chemotherapy Adherence | completed | N/A | 48 | Duke UniversityOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT00405678 | Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. | completed | Phase 1 / Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00638040 | The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression | withdrawn | — | 0 | Duke UniversityOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00362921 | Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 52 | Duke UniversityOTHER | 1 | Jul 10, 2014 | clinicaltrials |
| NCT00003466 | Temozolomide in Treating Patients With Progressive Low-Grade Glioma | completed | Phase 2 | 100 | Duke UniversityOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00005956 | Biological Therapy in Treating Patients With Advanced Cancer | completed | N/A | 3 | Duke UniversityOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00613093 | Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma | completed | Phase 2 | 67 | Duke UniversityOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00586014 | High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma | completed | Phase 2 | 91 | Duke UniversityOTHER | 0 | Jul 8, 2014 | clinicaltrials |
| NCT02157116 | Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 13 | Duke UniversityOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT01169415 | Effects of Steroid Tapering on Functional Capacity and Neurocognition | withdrawn | N/A | 0 | Duke UniversityOTHER | 0 | May 19, 2014 | clinicaltrials |
| NCT00606437 | Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants | completed | Phase 1 | 40 | Duke UniversityOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00510887 | Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma | terminated | Phase 2 | 14 | Duke UniversityOTHER | 1 | May 12, 2014 | clinicaltrials |
| NCT00597402 | Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas | completed | Phase 2 | 125 | Duke UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT00901225 | Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant | completed | Phase 2 | 21 | Duke UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT01491594 | Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 1 | Duke UniversityOTHER | 1 | Apr 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials